Clinical Trials : Encephalitis, Tick-Borne

Active, not recruiting

Study Name: Tick-Borne Encephalitis (TBE) Seropersistence After First Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)
Condition: Encephalitis, Tick-Borne
Date: 2009-04-30
Interventions: Biological: FSME-IMMUN 0.25 mL Junior (1.2 µg TBE antigen/0.25 mL) or FSME-IMMUN 0.5 mL (2.4µg TBE antigen/0.5 mL)

Completed

Study Name: TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)
Condition: Encephalitis, Tick-Borne
Date: 2005-09-08
Interventions: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) Subjects receive one vaccination with ei

Completed

Study Name: Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children
Condition: Encephalitis, Tick-Borne
Date: 2009-02-09
Interventions:

Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)

Completed

Study Name: TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)
Condition: Encephalitis, Tick-Borne
Date: 2007-07-17
Interventions: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) Vaccination by intramuscular injection i

Recruiting

Study Name: Tick-borne Encephalitis and Positive Borrelial Antibodies
Condition: Tick-borne Encephalitis
Date: 2014-07-20
Interventions:

Drug: Doxycycline Beside sympt

Completed

Study Name: Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
Condition: Tick-Borne Encephalitis
Date: 2005-07-08
Interventions:

Biological: LGT(TP21)/DEN4 Liv

Completed

Study Name: Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules
Condition: Tick Borne Encephalitis
Date: 2012-03-13
Interventions: Other: Blood Sampling Annual blood draws

Completed

Study Name: Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children
Condition: Encephalitis, Tick-borne
Date: 2005-09-08
Interventions: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl

Completed

Study Name: Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)
Condition: Encephalitis, Tick-borne
Date: 2005-09-08
Interventions: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl

Completed

Study Name: Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years
Condition: Encephalitis, Tick-borne
Date: 2005-09-08
Interventions: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)

Search for Clinical Trial Results

Encephalitis, Tick-Borne - 24 Studies Found

Status	Study
Active, not recruiting	Study Name: Tick-Borne Encephalitis (TBE) Seropersistence After First Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401) Condition: Encephalitis, Tick-Borne Date: 2009-04-30 Interventions: Biological: FSME-IMMUN 0.25 mL Junior (1.2 µg TBE antigen/0.25 mL) or FSME-IMMUN 0.5 mL (2.4µg TBE antigen/0.5 mL)
Completed	Study Name: TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209) Condition: Encephalitis, Tick-Borne Date: 2005-09-08 Interventions: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) Subjects receive one vaccination with ei
Completed	Study Name: Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children Condition: Encephalitis, Tick-Borne Date: 2009-02-09 Interventions: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
Completed	Study Name: TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223) Condition: Encephalitis, Tick-Borne Date: 2007-07-17 Interventions: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) Vaccination by intramuscular injection i
Recruiting	Study Name: Tick-borne Encephalitis and Positive Borrelial Antibodies Condition: Tick-borne Encephalitis Date: 2014-07-20 Interventions: Drug: Doxycycline Beside sympt
Completed	Study Name: Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults Condition: Tick-Borne Encephalitis Date: 2005-07-08 Interventions: Biological: LGT(TP21)/DEN4 Liv
Completed	Study Name: Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules Condition: Tick Borne Encephalitis Date: 2012-03-13 Interventions: Other: Blood Sampling Annual blood draws
Completed	Study Name: Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children Condition: Encephalitis, Tick-borne Date: 2005-09-08 Interventions: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
Completed	Study Name: Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225) Condition: Encephalitis, Tick-borne Date: 2005-09-08 Interventions: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
Completed	Study Name: Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years Condition: Encephalitis, Tick-borne Date: 2005-09-08 Interventions: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)